Founded in 2009 as the International Consortium of Stem Cell Research (INCOSC), Boyalife Group is a privately-held global biopharmaceutical holding company with 30 subsidiaries and affiliated companies operating in three distinct business segments: 1) cellular processing and biobanking for regenerative medicine, CAR-T and other emerging immunotherapies, 2) genomics and 3) drug discovery. Boyalife Group is headquarted in Wuxi City, China, and maintains operations in Tianjin, Guangzhou, Beijing, Seoul, South Korea, New Delhi, India and Sacramento, California, USA.
| Website | http://www.boyalifegroup.com |
| Revenue | $43.7 million |
| Employees | 43 (10 on RocketReach) |
| Founded | 2009 |
| Phone | +86 400 885 0012 |
| Technologies |
JavaScript
,
HTML
,
PHP
+12 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Research And Development, Stem Cell Research, Global Biopharma, Biopharmaceutical, Holding Company, Regenerative Medicine, Cell Therapy, Subsidiaries, Pharmaceutical Manufacturing, Biotechnology, Life Sciences, Drug Development, Clinical Trials, Genetic Engineering, Tissue Engineering, Bioprocessing, Pharmaceutical, Healthcare, Biologics, Therapeutics |
| Competitors | TissUse GmbH, Organogenesis, Athersys, Acelity, Regenative Labs, StemCells, Inc., Lorem Cytori USA, Inc, Tissue Regenix Group, Integra LifeSciences, Stempeutics Research Private Limited +33 more (view full list) |
Looking for a particular Boyalife employee's phone or email?
Boyalife Questions
The Boyalife annual revenue was $43.7 million in 2026.
Mingliang Guan is the Finance Director of Boyalife.
10 people are employed at Boyalife.
Top Boyalife Employees
-
11
-
新峰 李
Project Director at Boyalife
Shanghai, China
Related Companies
